Differing mechanisms of thrombin generation in live haematological and solid cancer cells determined by calibrated automated thrombography

Blood Coagulation and Fibrinolysis

Volumn 28, Issue 8, 2017, Pages 602-611

  Adesanya, Mufuliat Adeola ^a   Maraveyas, Anthony ^a   Madden, Leigh ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

calibrated automated thrombography; coagulation factor deficient plasma; thrombin generation; tissue factor; venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; THROMBIN; THROMBOPLASTIN;

ARTICLE; ASSAY; AUTOMATION; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CALIBRATED AUTOMATED THROMBOGRAPHY; CALIBRATION; CANCER ASSOCIATED THROMBOSIS; CANCER CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PLASMA; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SOLID MALIGNANT NEOPLASM; THROMBOCYTE FREE PLASMA; THROMBOSIS; VENOUS THROMBOEMBOLISM; BIOSYNTHESIS; BLOOD CELL; BLOOD CLOTTING TEST; KINETICS; METABOLISM; NEOPLASM; PATHOLOGY;

BLOOD CELLS; BLOOD COAGULATION TESTS; FACTOR VII; FACTOR XII; HUMANS; KINETICS; NEOPLASMS; THROMBIN;

EID: 85022198586     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000644     Document Type: Article

References (31)

1. Carrier M, Le Gal G, Tay J, Wu C, Lee AY. Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: A systematic review and meta-Analysis. J Thromb Haemost 2011; 9:653-663
2. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110:2339-2346
3. Dumitrascu DL, Suciu O, Grad C, Gheban D. Thrombotic complications of pancreatic cancer: classical knowledge revisited. Dig Dis 2010; 28:350-354
4. Cesarman-Maus G, Braggio E, Fonseca R. Thrombosis in multiple myeloma (MM). Hematology 2012; 17 (Suppl 1):S177-S180
5. Zangari M, Tricot G, Polavaram L, Zhan F, Finlayson A, Knight R, et al Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone. J Clin Oncol 2010; 28:132-135
6. Boccaccio C, Comoglio PM. Genetic link between cancer and thrombosis J Clin Oncol 2009; 27:4827-4833
7. Herring J, McMichael M. Diagnostic approach to small animal bleeding disorders. Top Companion Anim Med 2012; 27:73-80
8. Peetz D. Factor VIII Methods: Which Assay Principle for which Indication? 36th Hemophilia Symposium Hamburg 2005. 2016; 71-74
9. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15
10. Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 2012; 58:1252-1259
11. Tappenden KA, Gallimore MJ, Evans G, Mackie IJ, Jones DW. Thrombin generation: A comparison of assays using platelet-poor and-rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. Br J Haematol 2016; 139:106-112
12. Takamiya O, Sakata M. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram. Lab Hematol 2008; 14:39-44
13. Marchetti M, Diani E, ten Cate H, Falanga A. Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography. Haematologica 2012; 97: 1173-1180
14. Kuijpers MJ, van der Meijden PE, Feijge MA, Mattheij NJ, May F, Govers-Riemslag J, et al. Factor XII regulates the pathological process of thrombus formation on ruptured plaques. Arterioscler Thromb Vasc Biol 2014; 34:1674-1680
15. Giesen P. Outline of the method to measure thrombin generation using the calibrated automated thrombogram. Thrombogram Guide 2007;41-47
16. Welsh J, Smith JD, Yates KR, Greenman J, Maraveyas A, Madden LA Tissue factor expression determines tumour cell coagulation kinetics. Int J Lab Hematol 2012; 34:396-402
17. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88:576-582
18. Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008; 99:767-773
19. Butenas S, vant Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272:21527-21533
20. Yates KR, Welsh J, Echrish HH, Greenman J, Maraveyas A, Madden LA Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine. Blood Coagul Fibrinolysis 2011; 22:680-687
21. Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 1975; 15:741-747
22. Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro 1982; 18:24-34
23. Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, et al. Phenotype and Genotype of Pancreatic Cancer Cell Lines. Pancreas 2010; 39:425-435
24. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2006; 26:41-48
25. Woodruff RS, Sullenger B, Becker RC. Themany facesof thecontactpathway and their role in thrombosis. J Thromb Thrombolysis 2011; 32:9-20
26. Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F. Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost 2011; 9:306-315
27. Nickel KF, Ronquist G, Langer F, Labberton L, Fuchs TA, Bokemeyer C, et al. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-Associated thrombosis. Blood 2015; 126:1379-1389
28. Konings J, Govers-Riemslag JW, Philippou H, Mutch NJ, Borissoff JI, Allan P, et al. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 2011; 118:3942-3951
29. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer Chest 2003; 124:58S-68S
30. Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C. In vivo roles of factor XII. Blood 2012; 120:4296-4303
31. Rice NT, Szlam F, Varner JD, Bernstein PS, Szlam AD, Tanaka KA Differential contributions of intrinsic and extrinsic pathways to thrombin generation in adult, maternal and cord plasma samples. PLoS One 2016; 11:e0154127